The app for independent voices

Carmelite Quotes's avatar

Saint Mary of Jesus Crucified shares a heartfelt cry to Mary, the Mother who never abandoned her.

The Mother I Forgot
Matt Taibbi's avatar

Check out my new post!

NPR Should Be Axed Because it's Anti-Thought, Not Anti-Trump

You made it, you own it

You always own your intellectual property, mailing list, and subscriber payments. With full editorial control and no gatekeepers, you can do the work you most believe in.

JD Flynn's avatar
Two things from Rome
JM Kraemer/Lego Church Project's avatar

Still feeling pretty rough. Though I seem to be a bit calmer than I was yesterday.

Someone recently asked me how they could help given my current rough state of mind.

Pray.

Pray that I can secure a few displays for The Project. Because no matter what is going on in my life. Serving the Lord is the best way to help. It allows me to focus on following Christ and I can turn what I’m doing into an active prayer.

Pray that p…

Great discussions

Join the most interesting and insightful discussions.

Danielle Bean's avatar

What God asks is almost disappointingly simple: faithful attendance at ordinary Masses, small kindnesses to difficult people, and the courage to sit in silence with your own heart. 💙

The saints aren’t spiritual overachievers. They are ordinary people who consistently say yes in unremarkable moments.

2nd Smartest Guy in the World's avatar
Most Intensive Ivermectin Use Had 74 Percent Reduction in Excess Deaths in Peru: New Study
Bandit's avatar

My question is, does IVM still work against the newer varieties? (Clades?)

Unlike targeted therapies like monoclonal antibodies or the purported intention of the Mod RNA vaccines that target very specific antigens that can evolve very quickly rendering targeted treatments obsolete, IVM, HCQ, Flavonoids, Antihelmintics are host adaptive therapeutics making the overall cellular environment unfriendly for pathogens ie raising cellular PH, thus work against a wide variety of pathogens.

3 Likes
Aug 20, 2023
at
2:09 AM
No replies yet
Be the first to add your thoughts